ArticleFrontiers in neurology2025
Optic nerve sheath enhancement in patients with a new diagnosis of idiopathic intracranial hypertension.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Optic nerve sheath enhancement in patients with a new diagnosis of idiopathic intracranial hypertension.Frontiers in neurology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Optic nerve sheath enhancement (ONSE) is a radiologic sign commonly associated with a diagnosis of optic perineuritis. However, recent studies have reported this radiologic sign in patients with idiopathic intracranial hypertension (IIH). The presence of ONSE in patients with IIH may lead to optic perineuritis diagnosis in excess. We evaluated the prevalence of ONSE in patients with a new diagnosis of IIH. Methods: Retrospective study of consecutive patients who presented to the emergency department of our quaternary care center with a suspected intracranial pressure disorder between June 15, 2023 and July 1, 2024. Patients who received a new diagnosis of IIH fulfilling the 2013 revised diagnostic criteria and who underwent orbital magnetic resonance imaging (MRI) with fat-suppressed contrast-enhanced sequences were included. An expert neuroradiologist evaluated all orbital MRIs for the presence of ONSE. Results: Forty-three patients with a new diagnosis of IIH were included (mean age, 31 ± 7 years; 100% women; 72% Black, 20% White, and 8% other). Of these 43 patients, three were categorized as having suggested ONSE versus blood vessels. The remaining 40 patients were categorized as having no ONSE. Discussion: ONSE is a radiologic sign that may occur in approximately 7% of patients with newly diagnosed IIH. However, the distinction between mild ONSE and blood vessels surrounding or within the optic nerve sheath is challenging. A location at the distal infraorbital portion of the optic nerve sheath and a corkscrew appearance are suggestive of a vascular etiology. Awareness of this radiologic sign in patients with IIH is important to avoid optic perineuritis diagnosis in excess.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.